Lymphoma Program


Michael Filtz

Michael Filtz, Pharm.D., BCOP
Michael Filtz received his BS from University of Virginia in 2001 and his PharmD from University of Maryland in 2009. He completed his post graduate training years at University of Utah and Huntsman Cancer Hospitals. He started working on the hematology service in 2011 and enjoys working with patients to help manage their symptoms as they progress through treatment programs.

Jeff Gilreath Jeffrey Gilreath, Pharm.D.
Jeffrey Gilreath received his Doctor of Pharmacy from the University of Wisconsin - Madison in 2005.  He completed a one-year residency in clinical pharmacy practice at the University of Utah, and then a one-year residency in hematology/oncology pharmacy practice at the Medical University of South Carolina (MUSC) in Charleston, South Carolina.  After residency, he worked as a clinical pharmacist on the hematology and oncology wards, the stem cell transplant ward, the Huntsman Critical Care Unit, as well as the outpatient infusion center.  In 2012, he transitioned the hematology clinic to work specifically with patients with benign and malignant hematologic disorders.  His specific area of interest is helping to relieve patients’ symptoms during their cancer care.

Ashley Newland, PharmD, BCOP
Ashley Newland is a clinical pharmacist who specializes in caring for patients with leukemias and lymphomas. She received her PharmD from the University of Toledo in 2008. She then pursued residency training, completing her first year pharmacy residency at Lahey Clinic in Burlington, Massachusetts in 2009, followed by an oncology pharmacy residency at the University of Kentucky in 2010. She began working at Virginia Commonwealth University in 2010 as a clinical pharmacy specialist, caring for inpatients on the hematologic malignancies and bone marrow transplant services. Ashley joined the hematology clinic team at Huntsman Cancer Hospital in 2014. Her primary interests include supportive care, prevention and treatment of regimen-related toxicities, and oral chemotherapy.